This data file contains the responses of 337 participants who completed the SMA Screening Survey (UK). All participants live with Spinal Muscular Atrophy in some capacity (either having it themselves or having it in their family). Participants were asked about their views towards population genetic screening: pre-conception genetic screening, prenatal genetic screening and newborn genetic screening. They were also asked about their previous use of reproductive genetic technologies and their views on the wider issue of pregnancy termination. Data collection occurred between September 2014 and June 2015. A related data collection consisting of interview transcripts is also made available (see Related Resources)
Objectives and Methods: Many authors have argued that ethical, legal, and social issues (“ELSIs”) sh...
This study reports on the analysis of 59 in-depth interviews conducted with people diagnosed with, o...
This paper examines the issues of pre-natal genetic testing and its ethical and legal concerns. Part...
<p>Abstract copyright data collection owner.</p>This data file contains the responses of 337 partici...
<p>Abstract copyright data collection owner.</p>This collection consists of fifteen interviews with ...
Developments in genetics are rapidly changing the capacity and scope of screening practices. However...
Autosomal recessive conditions are a significant health burden with few treatments. Population carri...
Developments in genetics are rapidly changing the capacity and scope of screening practices. However...
Purpose: Autosomal recessive conditions, whilst individually rare, are a significant health burden w...
Background: Spinal muscular atrophy (SMA) is an inherited neuromuscular disorder and a leading g...
Spinal muscular atrophy (SMA) is the most common neuromuscular autosomal recessive disorder. The Ame...
Spinal muscular atrophy (SMA), a progressive neuromuscular condition, was recently added to state ne...
BACKGROUND: Spinal muscular atrophy (SMA) is the most common neuromuscular autosomal recessive disor...
Spinal muscular atrophy (SMA) is the most common genetic disease that causes infant mortality. Its t...
Spinal muscular atrophy (SMA) is the most common genetic disease that causes infant mortality. Its t...
Objectives and Methods: Many authors have argued that ethical, legal, and social issues (“ELSIs”) sh...
This study reports on the analysis of 59 in-depth interviews conducted with people diagnosed with, o...
This paper examines the issues of pre-natal genetic testing and its ethical and legal concerns. Part...
<p>Abstract copyright data collection owner.</p>This data file contains the responses of 337 partici...
<p>Abstract copyright data collection owner.</p>This collection consists of fifteen interviews with ...
Developments in genetics are rapidly changing the capacity and scope of screening practices. However...
Autosomal recessive conditions are a significant health burden with few treatments. Population carri...
Developments in genetics are rapidly changing the capacity and scope of screening practices. However...
Purpose: Autosomal recessive conditions, whilst individually rare, are a significant health burden w...
Background: Spinal muscular atrophy (SMA) is an inherited neuromuscular disorder and a leading g...
Spinal muscular atrophy (SMA) is the most common neuromuscular autosomal recessive disorder. The Ame...
Spinal muscular atrophy (SMA), a progressive neuromuscular condition, was recently added to state ne...
BACKGROUND: Spinal muscular atrophy (SMA) is the most common neuromuscular autosomal recessive disor...
Spinal muscular atrophy (SMA) is the most common genetic disease that causes infant mortality. Its t...
Spinal muscular atrophy (SMA) is the most common genetic disease that causes infant mortality. Its t...
Objectives and Methods: Many authors have argued that ethical, legal, and social issues (“ELSIs”) sh...
This study reports on the analysis of 59 in-depth interviews conducted with people diagnosed with, o...
This paper examines the issues of pre-natal genetic testing and its ethical and legal concerns. Part...